Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant

The global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become more serious because of the continuous emergence of variants of concern (VOC), thus calling for the development of broad-spectrum vaccines with greater efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Naru, Ji, Qianting, Liu, Zezhong, Tang, Kaiming, Xie, Yubin, Li, Kangchen, Zhou, Jie, Li, Sisi, Shang, Haotian, Shi, Zecan, Zheng, Tianyu, Yao, Jiawei, Lu, Lu, Yuan, Shuofeng, Jiang, Shibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950793/
https://www.ncbi.nlm.nih.gov/pubmed/35336907
http://dx.doi.org/10.3390/v14030501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950793/
https://www.ncbi.nlm.nih.gov/pubmed/35336907
http://dx.doi.org/10.3390/v14030501

Ejemplares similares